Augment Injectable
Payments companies reported to CMS as associated with Augment Injectable. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Augment Injectable, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Augment Injectable
These are the largest totals companies reported as associated with Augment Injectable. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Haddad | Glenview, IL | Orthopaedic Surgery | $145,674.40 |
| Timothy Achor | Houston, TX | Orthopaedic Trauma | $94,908.72 |
| Robert Wetzel | Cleveland, OH | Orthopaedic Trauma | $75,756.57 |
| Marcus Sciadini | Baltimore, MD | Orthopaedic Trauma | $73,470.05 |
| Michael Maceroli | Atlanta, GA | Orthopaedic Trauma | $67,725.00 |
| Richard Yoon | Jersey City, NJ | Orthopaedic Surgery | $62,251.16 |
| Joseph Hsu | Charlotte, NC | Orthopaedic Trauma | $53,000.00 |
| Cyril Mauffrey | Denver, CO | Orthopaedic Trauma | $52,565.00 |
| Henry Sagi | Cincinnati, OH | Orthopaedic Trauma | $45,850.00 |
| Sarah Pierrie | Charlotte, NC | Orthopaedic Surgery | $44,112.57 |
Prescribed Augment Injectable?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.